 |
|
EECP Therapy
A safe treatment option
for patients suffering
from angina and
other types of
heart disease.
For an appointment, call
1-800-801-8882.
For more info,
contact us.
|
|
EECP for Physicians
Patient Preparation
| Conduct a comprehensive pre-EECP therapy clinical status assessment by history and physical examination. |
Verify that the patient remains clinically stable before beginning EECP treatment. The heart failure patient should be stabilized for at least two weeks prior to initiating EECP therapy. |
| Fluid volume status must be managed, especially in the heart failure/LVD patient population. |
Monitor and adjust medical therapy to achieve and maintain a euvolemic state to prevent the onset or recurrence of fluid retention and pulmonary congestion. |
| EECP treatment should be withheld if there is exacerbatation of heart failure symptoms. |
Treatment may be resumed once symptoms have subsided and the patient has been stabilized. |
| Patients with severely compromised cardiac function appear to be at greater risk for adverse clinical events with EECP treatment. |
The rates of occurrence of adverse events are within expectations for patients with the types and severity of illnesses indicated for EECP treatment. |
| Careful patient selection, thorough patient evaluation before, during and after each treatment, vigilant patient monitoring, a properly equipped facility, and appropriate medical supervision will serve to optimize the safety and effectiveness of EECP therapy and minimize the possibility of adverse events. |
An EECP therapist skilled in patient assessment, experience in caring for angina and heart failure patients, and trained in the appropriate delivery of EECP therapy is key to the safe and effective administration of EECP treatments. |
|
